A track record of success indicates that using semaglutide for weight loss is a viable option, and it appears to us that semaglutide helps to maintain results for people who stick with a good diet and regular exercise
Ipamorelin contributes ghrelin-receptor stimulation (mimicking endogenous ghrelin)
These effects, independent of glucose lowering and weight loss, may contribute to CV benefits but are unlikely to fully explain MACE reductions
Clinical trials ongoing: Studies specifically examining semaglutide for NASH (non-alcoholic steatohepatitis, a more severe form of fatty liver disease) show promising results
Said to enhance fat loss by prioritizing adipose cell fat burning for energy, helping break weight loss plateaus
These medications stimulate GLP-1 receptors throughout the body, amplifying the impact of naturally produced metabolic hormones